Annovis is also seeking fresh capital while working to advance trials for both Alzheimer's and Parkinson's disease drugs.

The FDA has set a Prescription Drug User Fee Act action date for 24 May 2026.

Researchers have created a targeted compound that blocks an enzyme linked to inflammation in individuals with a genetic predisposition to Alzheimer’s disease, while still maintaining normal brain ...

The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...

Conventional treatments of Alzheimer's disease, one of the most common forms of dementia, have been largely focused on ...

The current edition of the Diagnostic and Statistical Manual is known as the DSM-5. What will the next version be called?

(Yicai) Jan. 27 -- China has suspended the import, sale, and use of an Alzheimer's treatment and an active pharmaceutical ...

A smart new platform developed by IIT Bombay unifies scattered brain-disease data to help researchers find markers, explore ...

Infusion therapies can be "life changing" for those suffering from chronic illnesses, founder Shaya Fogel said.

We are our own worst enemy When, oh when, is the American medical community going to accept the reality that this country’s biggest healthcare problem isn’t insurance or medications; ...

Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...